Skip Nav Destination
Issues
May 2002
ISSN 1424-8832
EISSN 1424-8840
In this Issue
Pathophysiology of Haemostasis and Thrombosis 2002, Vol. 32, No. 1
Editors’ Note
Supramolecular Biology
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (1): 1.
https://doi.org/10.1159/000057281
Original Paper
Resistance to Activated Protein C, Factor V Leiden and the Prothrombin G20210A Variant in Patients with Colorectal Cancer
Gregorios A. Paspatis; Aikaterini Sfyridaki; Nikolaos Papanikolaou; Kostantinos Triantafyllou; Aikaterini Livadiotaki; Andreas Kapsoritakis; Niki Lydataki
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (1): 2–7.
https://doi.org/10.1159/000057282
Failure of Platelet Parameters and Biomarkers to Correlate Platelet Function to Severity and Etiology of Heart Failure in Patients Enrolled in the EPCOT Trial: With Special Reference to the Hemodyne® Hemostatic Analyzer
Victor L. Serebruany; Marcus E. McKenzie; Andrew F. Meister; Sergey Y. Fuzaylov; Paul A. Gurbel; Dan Atar; Wendy A. Gattis; Christopher M. O’Connor
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (1): 8–15.
https://doi.org/10.1159/000057283
Effects of Aspirin and Clopidogrel versus Oral Anticoagulation on Platelet Function and on Coagulation in Patients with Nonvalvular Atrial Fibrillation (CLAFIB)
Iris Müller; Steffen Massberg; Wolfgang Zierhut; Christiane Binz; Alexander Schuster; Silja Rüdiger-von Hoch; Siegmund Braun; Meinrad Gawaz
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (1): 16–24.
https://doi.org/10.1159/000057284
Nitric Oxide-cGMP and Prostacyclin-cAMP Pathways in Patients with Type II Diabetes and Different Types of Retinopathy
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (1): 25–32.
https://doi.org/10.1159/000057285
Low-Dosage Intravenous Immunoglobulin in the Management of a Patient with Acquired von Willebrand Syndrome Associated with Monoclonal Gammopathy of Undetermined Significance
T. Hayashi; H. Yagi; H. Suzuki; Y. Nonaka; T. Nomura; Y. Sakurai; M. Shibata; M. Matsumoto; Y. Yamamoto; Y. Fujimura
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (1): 33–39.
https://doi.org/10.1159/000057286
Effects of the Magenstrasse and Mill Operation for Obesity on Plasma Plasminogen Activator Inhibitor Type 1, Tissue Plasminogen Activator, Fibrinogen and Insulin
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (1): 40–43.
https://doi.org/10.1159/000057287
Isolation of Endogenous Anticoagulant N-Sulfated Glycosaminoglycans in Human Plasma from Healthy Subjects
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (1): 44–49.
https://doi.org/10.1159/000057288
Further Section
Some Thoughts from Your Publisher
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (1): 50.
https://doi.org/10.1159/000057289
